Clinical Trial Update: Efficacy, Safety, and Pharmacokinetics of ThisCART19A Combined With Olverembatinib in Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia. [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 trial assessing the safety, efficacy signals, and pharmacokinetics of ThisCART19A combined with olverembatinib in patients with newly diagnosed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Drugs mentioned

• Olverembatinib (Olverembatinib)
• ThisCART19A (ThisCART19A)

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING